In 2015, ASH initiated an effort to update the 2011 ASH guidelines on Immune Thrombocytopenia (ITP). ASH appointed thirteen clinical experts, two methodologists and two patient representatives to review evidence and form twenty-four recommendations on ITP. The recommendations address treatment of both adult and pediatric ITP. Development of these guidelines, including systematic evidence review, was supported by the University of Oklahoma Health Sciences Center.
For the complete guidelines, please visit https://ashpublications.org/bloodadvances/article/3/23/3829/429213/American-Society-of-Hematology-2019-guidelines-for